(Q37547218)

20 August 2017

1 reference

title

Serenoa repens (saw palmetto): a systematic review of adverse events (English)

1 reference

20 August 2017

1 reference

Serenoa repens

1 reference

Taofikat B Agbabiaka

1

0 references

Edzard Ernst

series ordinal

4

object named as

Edzard Ernst

1 reference

20 August 2017

Max H Pittler

2

1 reference

20 August 2017

Barbara Wider

series ordinal

3

1 reference

20 August 2017

publication date

1 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

32

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

637-647

1 reference

A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200932080-00003

Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial

21 January 2018

1 reference

12 December 2020

A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome

1 reference

12 December 2020

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study

1 reference

12 December 2020

Treatment of lower urinary tract symptoms suggestive of benign prostatic obstruction in real life practice in France

1 reference

12 December 2020

Early urodynamic effects of the lipido-sterolic extract of Serenoa repens (Permixon(R)) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia

1 reference

12 December 2020

[Medical treatment of prostatic adenoma. Controlled trial: PA 109 vs placebo in 110 patients]

1 reference

12 December 2020

Do saw palmetto extracts block human alpha1-adrenoceptor subtypes in vivo?

1 reference

12 December 2020

[Five-year experience in treating patients with prostatic hyperplasia patients with permixone (Serenoa repens "Pierre Fabre Medicament)]

1 reference

12 December 2020

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

1 reference

12 December 2020

In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto.

1 reference

12 December 2020

Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis

1 reference

12 December 2020

Efficacy and tolerability of the lipidosterolic extract of Serenoa repens (Permixon) in benign prostatic hyperplasia: a double-blind comparison of two dosage regimens.

1 reference

12 December 2020

Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia

1 reference

12 December 2020

Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms

1 reference

12 December 2020

5alpha-reductase: history and clinical importance

1 reference

12 December 2020

Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients

1 reference

12 December 2020

Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers

1 reference

12 December 2020

A detailed safety assessment of a saw palmetto extract

1 reference

12 December 2020

Saw palmetto-induced pancreatitis

1 reference

12 December 2020

The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens.

1 reference

12 December 2020

Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms

1 reference

12 December 2020

Saw palmetto for benign prostatic hyperplasia

1 reference

12 December 2020

[Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo]

1 reference

12 December 2020

[Efficiency and safety of prostamol-Uno in patients with chronic abacterial prostatitis]

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia

1 reference

12 December 2020

Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.

1 reference

12 December 2020

Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration.

1 reference

12 December 2020

Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia

1 reference

12 December 2020

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

1 reference

12 December 2020

Saw palmetto and intraoperative floppy-iris syndrome

1 reference

12 December 2020

Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia

1 reference

12 December 2020

Adverse events associated with pediatric spinal manipulation: a systematic review

1 reference

12 December 2020

The value of permixon in benign prostatic hypertrophy

1 reference

12 December 2020

A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

1 reference

12 December 2020

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

12 December 2020

Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract

1 reference

12 December 2020

Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia

1 reference

12 December 2020

Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literature

1 reference

12 December 2020

Phytotherapy in treatment of benign prostatic hyperplasia: a critical review

1 reference

12 December 2020

10.2165/00002018-200932080-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

20 August 2017

1045187515

0 references

1 reference